Dan Andrews tests positive to Covid and will isolate with his entire family for a week
- Daniel Andrews tested positive for Covid after developing ‘mild symptoms’
- Premier took to Twitter to announce he would be isolating with his family
- Deputy premier James Merlino will temporarily take over role until April 4
Victorian Premier Daniel Andrews has tested positive for Covid after developing ‘mild symptoms’ on Monday morning.
Mr Andrews said he would isolate at home for a week along with his family and hand over the reins to Deputy Premier James Merlino until April 4.
‘After developing mild symptoms this morning including a sore throat and mild temperature, I undertook a rapid antigen test,’ he said.
Victorian Premier Daniel Andrews has tested positive for Covid after developing ‘mild symptoms’ on Monday morning
Mr Andrews said he would isolate at home for a week along with his family and hand over the reins to Deputy Premier James Merlino until April 4
The premier took to Twitter to say his family had stocked up on plenty of Panadol and that he will be ‘resting up’
‘So far, Cath and the kids have tested negative. As they are close contacts, they will also isolate for the next seven days.’
The premier took to Twitter to say his family had stocked up on plenty of Panadol and that he will be ‘resting up’.
Victoria recorded 8,739 new Covid cases on Monday and has 56,997 active infections as more people catch the more contagious BA.2 Omicron sub-variant.
There are 252 patients in hospital, including 21 in ICU and six on ventilators.
Melbourne researchers have created two new COVID-19 vaccines which could provide better immunity to the virus than any other vaccination in the world.
More than 100 Victorians, aged 18 to 70, are being recruited to participate in a trial for the Melbourne-made RBD protein vaccine and RBD mRNA vaccine.
The new jabs, created by scientists from the Doherty Institute and Monash Institute of Pharmaceutical Science, are distinct from all existing vaccines.
They focus on the immune response on the tip of the SARS-CoV-2 spike protein, called the receptor binding domain.
The RBD enables the virus to enter and infect cells in the body and can elicit more than 90 per cent of neutralising antibodies to block the virus following infection.
The vaccines may also provide immunity to the Omicron variant and more serious future variants, as they are ‘proof-of-principle’ variant vaccines.
‘As well as inducing strong neutralising antibody immunity to the Beta variant in mice, it also retains its potential to neutralise the original ancestral strain, and preliminary in-lab studies have demonstrated neutralising activity against other variants including Delta and Omicron,’ Doherty Institute researcher Georgia Deliyannis said.
More to come.
***
Read more at DailyMail.co.uk